FDA Nominee Clears Senate Panel Despite Dems' Criticism
The Senate Committee on Health, Education, Labor and Pensions on Thursday advanced the nomination of Scott Gottlieb to lead the U.S. Food and Drug Administration, a vote that included modest support...To view the full article, register now.
Already a subscriber? Click here to view full article